Denver, CO – According to filings with the U.S. Securities and Exchange Commission, RxRevu is raising $8,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Kyle Kiser played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About RxRevu
At RxRevu we believe in improving the value of healthcare through informed, consistent prescription decisions. We also believe that lasting changes require a dedicated intention and aligned effort, and we are committed to investing in the future of healthcare. We leverage our platform to deliver real-time, patient-specific cost information, electronic prior authorization, and therapeutic alternatives at the point of care. By doing so, we enable shared decisions between providers and patients, help patients get the right medication the first time, and remove friction from the point of care to fulfillment. We value mission-driven individuals with integrity, self-awareness, and curiosity. At RxRevu, we pride ourselves on a culture of fun, accountability, and autonomy, and working hard on interesting problems while maintaining a healthy work/life balance.

To learn more about RxRevu, visit http://rxrevu.com/

Contact:
Kyle Kiser, Chief Executive Officer
800-360-4965
kyle.kiser@rxrevu.com
https://www.linkedin.com/in/kyle-kiser-68ba218/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved